147 related articles for article (PubMed ID: 20533939)
1. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
Ibrahim SF; Singer JP; Arron ST
Dermatol Surg; 2010 Nov; 36(11):1752-5. PubMed ID: 20533939
[No Abstract] [Full Text] [Related]
2. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
Vadnerkar A; Nguyen MH; Mitsani D; Crespo M; Pilewski J; Toyoda Y; Bermudez C; Kwak EJ; Silveira FP; Clancy CJ
J Heart Lung Transplant; 2010 Nov; 29(11):1240-4. PubMed ID: 20591690
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
4. Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
Zwald FO; Spratt M; Lemos BD; Veledar E; Lawrence C; Marshall Lyon G; Chen SC
Dermatol Surg; 2012 Aug; 38(8):1369-74. PubMed ID: 22551390
[TBL] [Abstract][Full Text] [Related]
5. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
McCarthy KL; Playford EG; Looke DF; Whitby M
Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
[TBL] [Abstract][Full Text] [Related]
6. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
7. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
Vanacker A; Fabré G; Van Dorpe J; Peetermans WE; Maes B
Am J Transplant; 2008 Apr; 8(4):877-80. PubMed ID: 18261173
[TBL] [Abstract][Full Text] [Related]
8. Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O; Leccia MT; Blanche S; Chosidow O; Mamzer-Bruneel MF; Ravaud P; Thiebaut A; Villier C; Lortholary O
Med Mal Infect; 2011 Dec; 41(12):639-45. PubMed ID: 22055586
[TBL] [Abstract][Full Text] [Related]
9. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study.
Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Younus M; Mo J; Yan J; Ussetti P; Chin-Hong PV; Solé A; Holmes-Liew CL; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Aram J; Singer LG; Husain S
Am J Transplant; 2018 Jan; 18(1):113-124. PubMed ID: 28898527
[TBL] [Abstract][Full Text] [Related]
11. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
[No Abstract] [Full Text] [Related]
12. [Biliary lithiasis and cholecystitis with voriconazole: about 3 cases].
Gérardin-Marais M; Allain-Veyrac G; Danner I; Jolliet P
Therapie; 2006; 61(4):367-9. PubMed ID: 17124955
[No Abstract] [Full Text] [Related]
13. [Careful: skins cancers and voriconazole].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2011 Nov; 138(11):805-6. PubMed ID: 22078051
[No Abstract] [Full Text] [Related]
14. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
Wise SM; Wilson MA
Clin Nucl Med; 2011 Mar; 36(3):242-4. PubMed ID: 21285691
[TBL] [Abstract][Full Text] [Related]
15. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
Epaulard O; Saint-Raymond C; Villier C; Charles J; Roch N; Beani JC; Leccia MT
Clin Microbiol Infect; 2010 Sep; 16(9):1362-4. PubMed ID: 19930272
[TBL] [Abstract][Full Text] [Related]
16. [Voriconazole safety: short review of clinical data].
Veselov AV; Belousov DIu
Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
[No Abstract] [Full Text] [Related]
17. Pseudoporphyria associated with voriconazole.
Kwong WT; Hsu S
J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
[TBL] [Abstract][Full Text] [Related]
18. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
Wang TF; Wang T; Altman R; Eshaghian P; Lynch JP; Ross DJ; Belperio JA; Weigt SS; Saggar R; Gregson A; Kubak B; Saggar R
Am J Transplant; 2009 Dec; 9(12):2845-50. PubMed ID: 19845595
[TBL] [Abstract][Full Text] [Related]
19. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Tedja R; El-Sherief A; Olbrych T; Gordon S
Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
[TBL] [Abstract][Full Text] [Related]
20. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
